drugset / Trial / NCT03263117

SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke

NCT03263117 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Objectives: This study aims to estimate overall treatment benefit (improvement in disability) among acute ischemic stroke patients that are randomized to General Anesthesia (GA) compared with Sedation (CS) during endovascular therapy. Assess safety (as measured by incidence of symptomatic intracranial hemorrhage); rates of Endovascular therapy (EVT) procedural complications, reperfusion; and quality of life. Hypothesis: GA during EVT for acute ischemic stroke improves functional outcomes at 90 days compared to sedation.

Timeline

Start
2018-07-01
Primary completion
2023-04-22
Completion
2023-04-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Desflurane Other / unclassified — —
Comparator Dexmedetomidine Other / unclassified — —
Comparator Etomidate Small molecule — —
Comparator Fentanyl Other / unclassified — —
Comparator Lidocaine Other / unclassified — —
Comparator Midazolam Small molecule — —
Comparator Propofol Small molecule — Intravenous
Comparator Rocuronium Other / unclassified — —
Comparator Sevoflurane Other / unclassified — —
Comparator Suxamethonium Other / unclassified — —
Comparator Vecuronium Small molecule — —

Indications